PT-141 (Bremelanotide) — Dosing, Cycles, Half-Life & Side Effects
PT-141 (Bremelanotide) is a melanocortin receptor agonist peptide with a half-life of 2-3 hours. FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder (HSDD) in premenopausal women. Increases sexual desire through central nervous system mechanisms, not hormonal pathways. This page is educational harm-reduction reference compiled from peer-reviewed literature — not medical advice, not an endorsement, not a recommendation to use. Consult a licensed clinician before any decision.
Quick Facts
| Class | Melanocortin Receptor Agonist |
|---|---|
| Half-life | 2-3 hours |
| Hepatotoxicity | None |
| Suppression | 0/10 |
Typical Dosing Ranges
Common dose range: 0.5-2mg subcutaneous as needed (45 min before activity)
Cycle length: As needed (not daily)
Dose ranges are compiled from published pharmacokinetic studies and community-reported usage. Where a value is community-reported rather than clinically studied, this page and its structured data flag it. Lower end of any range is always the safer starting point.
Stacking Considerations
- No structural stacking blockers. Standard harm-reduction rules apply: minimize total androgen load, minimize oral exposure, and monitor bloodwork.
PCT Requirements
- Never stack two SERMs. Extend a single SERM (tamoxifen OR enclomiphene/clomiphene) rather than combining.
- Use the cycle planner to generate a full protocol based on your complete stack, not this compound alone.
Side Effect Profile
- Nausea very common (40%)
- Flushing
- Can raise blood pressure temporarily
- Expensive
- Not for daily use (max 8 doses/month per FDA label)
Known Interactions
No compound-specific interactions are catalogued in the current matrix. This does not mean no risk exists — it means there is no curated pairwise entry. Browse the full interaction matrix to cross-reference manually.
Related compounds
Monitoring (Bloodwork & Vitals)
- Comprehensive metabolic panel (baseline, mid-cycle, post-cycle)
- Lipid panel (total cholesterol, HDL, LDL, triglycerides)
- CBC (hemoglobin, hematocrit — watch for erythrocytosis)
- Sex-hormone panel (Total T, Free T, Estradiol sensitive, SHBG, LH, FSH)
- Blood pressure (weekly self-check; flag systolic >140 or diastolic >90)
Baseline bloodwork is recommended before any cycle. Discontinue if liver enzymes exceed 3× upper limit of normal or if hematocrit exceeds 54%.
Frequently Asked Questions
What is the half-life of PT-141 (Bremelanotide)?
PT-141 (Bremelanotide) has a half-life of approximately 2-3 hours. This figure is used to determine injection frequency (for esters) and post-cycle clearance timing.
What is the typical dose range for PT-141 (Bremelanotide)?
Commonly reported ranges for PT-141 (Bremelanotide): 0.5-2mg subcutaneous as needed (45 min before activity). Cycle length: As needed (not daily). These are compiled from published studies and community-reported usage — individual response varies and lower end is always preferred.
Does PT-141 (Bremelanotide) suppress natural testosterone?
PT-141 (Bremelanotide) causes minimal suppression of the HPTA axis (score 0/10). PCT may still be advisable depending on stack and duration.
What is PT-141 (Bremelanotide) typically used for?
PT-141 (Bremelanotide) is commonly used for: Sexual dysfunction, Libido enhancement, HSDD treatment. Intended-use context does not imply safety — every use case carries the same underlying pharmacological risks.
Is PT-141 (Bremelanotide) legal?
PT-141 (Bremelanotide) is a controlled substance in many jurisdictions (typically Schedule III in the US when it is an anabolic androgenic steroid). StackItSmart does not provide sourcing information. Possession, import, and use without a prescription carry legal consequences that vary by country and state.
Citations
Disclaimer
StackItSmart is an independent harm-reduction reference. The content above is compiled from peer-reviewed literature and is not medical advice, not an endorsement, and not a recommendation to use PT-141 (Bremelanotide). Performance-enhancing compounds carry legal, endocrine, cardiovascular, and hepatic risks. Consult a licensed clinician before any decision. StackItSmart does not provide sourcing, procurement, or dosing prescriptions.